From Postdoc to Biotech CEO: A Conversation with Sander Wuyts, CEO of ImmuneWatch

BiotechNews.nl published an in-depth interview with ImmuneWatch CEO Sander Wuyts, exploring his journey from academia to biotech entrepreneurship.

In the interview by Karen De Ceunynck, Sander shares how he transitioned from a bioscience engineering background at the University of Antwerp and KU Leuven, through a postdoc at EMBL Heidelberg in Peer Bork's lab, to co-founding ImmuneWatch in September 2021.

Key topics covered in the conversation include:

The path from PhD to CEO: Sander describes how at two pivotal career moments he was convinced he would leave academia, yet chose academic paths. His postdoc at EMBL was driven by the institute's international atmosphere and the opportunity to grow beyond science. He also co-founded Kultured, a small fermentation company, with his brother, an experience that gave him hands-on business skills and the confidence to make the leap to CEO.

Advice for PhDs considering entrepreneurship: Sander emphasises that the eagerness to learn, which drives PhD research, should extend beyond science into sales, business development, and operations. He highlights the importance of networking, sharing ideas openly to get feedback, and finding experienced advisors.

On focus and saying no: A lesson learned the hard way. Curiosity is great, but protecting your energy and being intentional about your path matters just as much.

Read the full interview on BiotechNews.nl.